CORRESP 1 filename1.htm kool20180515_corresp.htm

CESCA THERAPEUTICS INC.

 

2711 Citrus Road

Rancho Cordova, California 95742

 

May 16, 2018

 

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C. 20549

Attention: Ms. Heather Percival

 

 

Re:

Cesca Therapeutics Inc.

   

Registration Statement on Form S-1 (Registration No. 333-224185)

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant, Cesca Therapeutics Inc. (the “Registrant”), hereby requests acceleration of effectiveness of its above-referenced Registration Statement to 11:00 A.M., Eastern time, on May 16, 2018, or as soon as practicable thereafter. The Registrant respectfully requests that you notify Mr. Curt Creely of Foley & Lardner LLP of such effectiveness by a telephone call to (813) 225-4122.

 

 

Very truly yours,

 

Cesca Therapeutics Inc.

   
   
  By:  /s/ Vivian Liu
 

Vivian Liu

Chief Operating Officer